The purchasable chemical space: A detailed picture

Journal of Chemical Information and Modeling

Volumn 55, Issue 5, 2015, Pages 915-924

  Lucas, Xavier ^a   Grüning, Björn A ^a   Bleher, Stefan ^a   Günther, Stefan ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITAL LIBRARIES; LIBRARIES; MOLECULES; PHYSICOCHEMICAL PROPERTIES; PROTEINS; ZINC;

BUILDING BLOCKES; DIVERSITY ANALYSIS; FILTERING RULES; MEDICINAL CHEMISTRY; NATURAL PRODUCTS; PROTEIN-PROTEIN INTERACTIONS; SHAPE COMPLEXITY; VIRTUAL SCREENING;

ARSENIC COMPOUNDS;

BIOLOGICAL PRODUCT; MOLECULAR LIBRARY;

CHEMISTRY; DRUG DATABASE; DRUG DEVELOPMENT; DRUG REPOSITIONING; ECONOMICS; INFORMATION SCIENCE; MOLECULAR LIBRARY; PHYSICAL CHEMISTRY; PROCEDURES;

BIOLOGICAL PRODUCTS; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; DRUG REPOSITIONING; INFORMATICS; PHYSICOCHEMICAL PROCESSES; SMALL MOLECULE LIBRARIES;

EID: 84930221700     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/acs.jcim.5b00116     Document Type: Article

References (57)

1. Ruddigkeit, L.; van Deursen, R.; Blum, L. C.; Reymond, J. L. Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 J. Chem. Inf. Model. 2012, 52, 2864-2875
2. Sukumar, N.; Das, S. Current Trends in Virtual High Throughput Screening Using Ligand-Based and Structure-Based Methods Comb. Chem. High Throughput Screen. 2011, 14, 872-888
3. Lucas, X.; Wohlwend, D.; Hügle, M.; Schmidtkunz, K.; Gerhardt, S.; Schüle, R.; Jung, M.; Einsle, O.; Günther, S. 4-Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading Angew. Chem. Int. Ed. Engl. 2013, 52, 14055-14059
4. Macarron, R.; Banks, M. N.; Bojanic, D.; Burns, D. J.; Cirovic, D. A.; Garyantes, T.; Green, D. V.; Hertzberg, R. P.; Janzen, W. P.; Paslay, J. W.; Schopfer, U.; Sittampalam, G. S. Impact of High-Throughput Screening in Biomedical Research Nat. Rev. Drug Discovery 2011, 10, 188-195
5. Harvey, A. L. Natural Products in Drug Discovery Drug Discovery Today 2008, 13, 894-901
6. Lipinski, C. A. Drug-Like Properties and the Causes of Poor Solubility and Poor Permeability J. Pharmacol. Toxicol. Methods 2000, 44, 235-249
7. Hann, M. M.; Oprea, T. I. Pursuing the Leadlikeness Concept in Pharmaceutical Research Curr. Opin. Chem. Biol. 2004, 8, 255-263
8. Zhou, J. Z. Chemoinformatics and Library Design Methods Mol. Biol. 2011, 685, 27-52
9. Dolle, R. E. Historical Overview of Chemical Library Design Methods Mol. Biol. 2011, 685, 3-25
10. Cragg, G. M.; Newman, D. J. Natural Products: A Continuing Source of Novel Drug Leads Biochim. Biophys. Acta 2013, 1830, 3670-3695
11. Patel, R. N. Chemo-Enzymatic Synthesis of Pharmaceutical Intermediates Expert Opin. Drug Discovery 2008, 3, 187-245
12. Hou, J.; Liu, X.; Shen, J.; Zhao, G.; Wang, P. G. The Impact of Click Chemistry in Medicinal Chemistry Expert Opin. Drug Discovery 2012, 7, 489-501
13. Gantt, R. W.; Peltier-Pain, P.; Thorson, J. S. Enzymatic Methods for Glyco(Diversification/Randomization) of Drugs and Small Molecules Nat. Prod. Rep. 2011, 28, 1811-1853
14. Kodadek, T. The Rise, Fall and Reinvention of Combinatorial Chemistry Chem. Commun. (Camb.) 2011, 47, 9757-9763
15. Pollier, J.; Moses, T.; Goossens, A. Combinatorial Biosynthesis in Plants: A (P)Review on Its Potential and Future Exploitation Nat. Prod. Rep. 2011, 28, 1897-1916
16. Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. Zinc: A Free Tool to Discover Chemistry for Biology J. Chem. Inf. Model. 2012, 52, 1757-1768
17. Daga, P. R.; Polgar, W. E.; Zaveri, N. T. Structure-Based Virtual Screening of the Nociceptin Receptor: Hybrid Docking and Shape-Based Approaches for Improved Hit Identification J. Chem. Inf. Model. 2014, 54, 2732-2743
18. Lucas, X.; Simon, S.; Schubert, R.; Günther, S. Discovery of the Inhibitory Effect of a Phosphatidylinositol Derivative on P-Glycoprotein by Virtual Screening Followed by in Vitro Cellular Studies PLoS One 2013, 8, e60679
19. Parmenopoulou, V.; Kantsadi, A. L.; Tsirkone, V. G.; Chatzileontiadou, D. S.; Manta, S.; Zographos, S. E.; Molfeta, C.; Archontis, G.; Agius, L.; Hayes, J. M.; Leonidas, D. D.; Komiotis, D. Structure Based Inhibitor Design Targeting Glycogen Phosphorylase B. Virtual Screening, Synthesis, Biochemical and Biological Assessment of Novel N-Acyl-Beta-D-Glucopyranosylamines Bioorg. Med. Chem. 2014, 22, 4810-4825
20. Chen, C.; Wang, T.; Wu, F.; Huang, W.; He, G.; Ouyang, L.; Xiang, M.; Peng, C.; Jiang, Q. Combining Structure-Based Pharmacophore Modeling, Virtual Screening, and in Silico Admet Analysis to Discover Novel Tetrahydro-Quinoline Based Pyruvate Kinase Isozyme M2 Activators with Antitumor Activity Drug Des. Devel. Ther. 2014, 8, 1195-1210
21. ChemicalToolBoX. https://github.com/bgruening/galaxytools/tree/master/chemicaltoolbox (accessed February 10, 2015).
22. Baell, J. B.; Holloway, G. A. New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays J. Med. Chem. 2010, 53, 2719-2740
23. Clemons, P. A.; Bodycombe, N. E.; Carrinski, H. A.; Wilson, J. A.; Shamji, A. F.; Wagner, B. K.; Koehler, A. N.; Schreiber, S. L. Small Molecules of Different Origins Have Distinct Distributions of Structural Complexity That Correlate with Protein-Binding Profiles Proc. Natl. Acad. Sci. U S A 2010, 107, 18787-18792
24. Lovering, F.; Bikker, J.; Humblet, C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success J. Med. Chem. 2009, 52, 6752-6756
25. Hann, M. M.; Leach, A. R.; Harper, G. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery J. Chem. Inf. Comput. Sci. 2001, 41, 856-864
26. Lucas, X.; Günther, S. Using Chiral Molecules as an Approach to Address Low-Druggability Recognition Sites J. Comput. Chem. 2014, 35, 2114-2121
27. Bickerton, G. R.; Paolini, G. V.; Besnard, J.; Muresan, S.; Hopkins, A. L. Quantifying the Chemical Beauty of Drugs Nat. Chem. 2012, 4, 90-98
28. Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A Rule of Three for Fragment-Based Lead Discovery? Drug Discovery Today 2003, 8, 876-877
29. Morelli, X.; Bourgeas, R.; Roche, P. Chemical and Structural Lessons from Recent Successes in Protein-Protein Interaction Inhibition (2P2I) Curr. Opin. Chem. Biol. 2011, 15, 475-481
30. Ertl, P.; Roggo, S.; Schuffenhauer, A. Natural Product-Likeness Score and Its Application for Prioritization of Compound Libraries J. Chem. Inf. Model. 2008, 48, 68-74
31. OBoyle, N. M.; Banck, M.; James, C. A.; Morley, C.; Vandermeersch, T.; Hutchison, G. R. Open Babel: An Open Chemical Toolbox J. Cheminform. 2011, 3, 33
32. Chen, C. Y. Tcm Database@Taiwan: The Worlds Largest Traditional Chinese Medicine Database for Drug Screening in Silico PLoS One 2011, 6, e15939
33. Chapman and Hall Dictionary of Natural Products. http://dnp.chemnetbase.com (accessed September 15, 2008).
34. Lucas, X.; Senger, C.; Erxleben, A.; Grüning, B. A.; Döring, K.; Mosch, J.; Flemming, S.; Gunther, S. StreptomeDB: A Resource for Natural Compounds Isolated from Streptomyces Species Nucleic Acids Res. 2013, 41, D1130-1136
35. Saubern, S.; Guha, R.; Baell, J. B. Knime Workflow to Assess Pains Filters in Smarts Format. Comparison of RDKit and Indigo Cheminformatics Libraries Mol. Inf. 2011, 30, 847-850
36. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. DrugBank 3.0: A Comprehensive Resource for Omics Research on Drugs Nucleic Acids Res. 2011, 39, D1035-1041
37. Langdon, S. R.; Brown, N.; Blagg, J. Scaffold Diversity of Exemplified Medicinal Chemistry Space J. Chem. Inf. Model. 2011, 51, 2174-2185
38. Chemical Abstracts Service (CAS). http://www.cas.org (accessed December 10, 2014).
39. iResearch Library. www.chemnavigator.com/cnc/products/iRL.asp (accessed December 10, 2014).
40. Welsch, M. E.; Snyder, S. A.; Stockwell, B. R. Privileged Scaffolds for Library Design and Drug Discovery Curr. Opin. Chem. Biol. 2010, 14, 347-361
41. Boguski, M. S.; Mandl, K. D.; Sukhatme, V. P. Drug Discovery. Repurposing with a Difference Science 2009, 324, 1394-1395
42. Gupta, S. C.; Sung, B.; Prasad, S.; Webb, L. J.; Aggarwal, B. B. Cancer Drug Discovery by Repurposing: Teaching New Tricks to Old Dogs Trends Pharmacol. Sci. 2013, 34, 508-517
43. Proudfoot, J. R. The Evolution of Synthetic Oral Drug Properties Bioorg. Med. Chem. Lett. 2005, 15, 1087-1090
44. Zuegg, J.; Cooper, M. A. Drug-Likeness and Increased Hydrophobicity of Commercially Available Compound Libraries for Drug Screening Curr. Top. Med. Chem. 2012, 12, 1500-1513
45. Baell, J.; Walters, M. A. Chemistry: Chemical Con Artists Foil Drug Discovery Nature 2014, 513, 481-483
46. Gregori-Puigjane, E.; Mestres, J. Coverage and Bias in Chemical Library Design Curr. Opin. Chem. Biol. 2008, 12, 359-365
47. Yusof, I.; Segall, M. D. Considering the Impact Drug-Like Properties Have on the Chance of Success Drug Discovery Today 2013, 18, 659-666
48. Scott, D. E.; Coyne, A. G.; Hudson, S. A.; Abell, C. Fragment-Based Approaches in Drug Discovery and Chemical Biology Biochemistry 2012, 51, 4990-5003
49. Braisted, A. C.; Oslob, J. D.; Delano, W. L.; Hyde, J.; McDowell, R. S.; Waal, N.; Yu, C.; Arkin, M. R.; Raimundo, B. C. Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly J. Am. Chem. Soc. 2003, 125, 3714-3715
50. Bourgeas, R.; Basse, M. J.; Morelli, X.; Roche, P. Atomic Analysis of Protein-Protein Interfaces with Known Inhibitors: The 2P2I Database PLoS One 2010, 5, e9598
51. Hajduk, P. J.; Greer, J. A Decade of Fragment-Based Drug Design: Strategic Advances and Lessons Learned Nat. Rev. Drug Discovery 2007, 6, 211-219
52. Bower, J. F.; Pannifer, A. Using Fragment-Based Technologies to Target Protein-Protein Interactions Curr. Pharm. Des. 2012, 18, 4685-4696
53. Leach, A. R.; Hann, M. M. Molecular Complexity and Fragment-Based Drug Discovery: Ten Years On Curr. Opin. Chem. Biol. 2011, 15, 489-496
54. Dandapani, S.; Marcaurelle, L. A. Grand Challenge Commentary: Accessing New Chemical Space for Undruggable Targets Nat. Chem. Biol. 2010, 6, 861-863
55. Koster, H.; Craan, T.; Brass, S.; Herhaus, C.; Zentgraf, M.; Neumann, L.; Heine, A.; Klebe, G. A Small Nonrule of 3 Compatible Fragment Library Provides High Hit Rate of Endothiapepsin Crystal Structures with Various Fragment Chemotypes J. Med. Chem. 2011, 54, 7784-7796
56. Wilde, F.; Link, A. Advances in the Design of a Multipurpose Fragment Screening Library Expert Opin. Drug Discovery 2013, 8, 597-606
57. Bembenek, S. D.; Tounge, B. A.; Reynolds, C. H. Ligand Efficiency and Fragment-Based Drug Discovery Drug Discovery Today 2009, 14, 278-283